2020International Urology and NephrologyRequires access

Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer

İrem Bilgetekin, İsmail Ertürk, Fatma Buğdaycı Başal, Cengiz Karaçin, Nuri Karadurmuş, Berna Öksüzoğlu, Umut Demırcı

Open publisher page 15 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tolvaptan, Medicine, Hyponatremia, Nephrology, Antidiuretic, Internal medicine, Syndrome of inappropriate antidiuretic hormone secretion, Cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer — Research Paper | ScholarLens